NEOGEN
NEOGEN CHEMICALS LIMITED
Each stock's 10,000-path forecast, rendered as light.
NEOGEN CHEMICALS LIMITED (NEOGEN) Stock Analysis & Case Study
Is NEOGEN a good buy? The data-driven verdict.
NEOGEN CHEMICALS LIMITED (NEOGEN) trades at ₹2,032,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 28/100.
On the numbers, NEOGEN CHEMICALS LIMITED (NEOGEN) high-risk on the numbers, a Downstox Snapshot Score of 28/100, weighing expensive at 156.0× earnings, ROE of 3.6%, a 50% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
NEOGEN fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How NEOGEN ranks against the 2,373 companies in our screener
- NEOGEN's market cap of 5,564 Cr ranks in the 67th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NEOGEN's book value of ₹309 ranks in the 81st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NEOGEN's promoter holding of 53.0% ranks in the 37th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NEOGEN's 3-year profit (PAT) growth of -17.0% ranks in the 13th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NEOGEN's 3-year revenue growth of 8.0% ranks in the 44th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NEOGEN's debt-to-equity ratio of 1.71x is lower than 6% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is NEOGEN overvalued? NEOGEN P/E vs peers
NEOGEN trades at 156.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
NEOGEN share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 7.1y of NEOGEN history (29%/yr drift, 50%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| NEOGEN 2027 | ₹1,064 | ₹2,024 | ₹3,849 | -0% |
| NEOGEN 2028 | ₹813 | ₹2,016 | ₹4,998 | -1% |
| NEOGEN 2029 | ₹657 | ₹2,008 | ₹6,134 | -1% |
| NEOGEN 2030 | ₹554 | ₹2,000 | ₹7,217 | -2% |
| NEOGEN 2031 | ₹464 | ₹1,992 | ₹8,553 | -2% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability NEOGEN goes up, or doubles?
The bull case for NEOGEN
- NEOGEN CHEMICALS LIMITED is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹6,134.
The bear case & risks
- NEOGEN's P/E of 156.0x is lower than 7% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NEOGEN's return on equity of 3.6% ranks in the 25th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹657.
NEOGEN volatility & expected range, how bumpy is the ride?
Over the last 7.1 years NEOGEN compounded at 29%/year with annualized volatility of 50%. That volatility implies a 1-year 80% range of ₹1,064-₹3,849, the honest backbone behind any single price target.
NEOGEN price forecast, the full 60-month probability fan
NEOGEN price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds NEOGEN hits common targets within the simulated horizon?
Full multi-horizon detail on the NEOGEN price target & forecast page.
NEOGEN Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. NEOGEN scores 4/8, mixed financial health.
NEOGEN MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy NEOGEN with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 37.40% | 2.7× |
| Zerodha | 37.35% | 2.7× |
| Groww | 37.52% | 2.7× |
| Dhan | 37.35% | 2.7× |
| Kotak NeoCHEAPEST | 37.31% | 2.7× |
| Paytm Money | 37.69% | 2.7× |
| Pocketful | 37.75% | 2.6× |
| Anand Rathi | 37.35% | 2.7× |
| Bajaj Broking | 39.00% | 2.6× |
| Share India | 37.48% | 2.7× |
Compare every broker on the NEOGEN MTF page.
About NEOGEN CHEMICALS LIMITED: sector, index & market-cap context
NEOGEN CHEMICALS LIMITED (NEOGEN) is a small-cap NSE-listed company, with a market capitalisation of ₹5,564 Cr. See more stocks on our screener.
How the NEOGEN Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of NEOGEN CHEMICALS LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
NEOGEN analysis, FAQs
Is NEOGEN CHEMICALS LIMITED (NEOGEN) a good buy?
On the numbers, NEOGEN CHEMICALS LIMITED (NEOGEN) high-risk on the numbers, a Downstox Snapshot Score of 28/100, weighing expensive at 156.0× earnings, ROE of 3.6%, a 50% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is NEOGEN overvalued or undervalued?
NEOGEN trades at 156.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the NEOGEN share price target for 2031?
NEOGEN's probability-weighted 2031 median target is ₹1,992, with an 80% range of ₹464-₹8,553 (10,000-path Monte-Carlo).
What is the probability NEOGEN doubles in 5 years?
The modelled probability of NEOGEN reaching ₹4,064 (2×) within 5 years is 26%.
What is the bull case for NEOGEN?
NEOGEN CHEMICALS LIMITED is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in NEOGEN?
NEOGEN's P/E of 156.0x is lower than 7% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. NEOGEN's return on equity of 3.6% ranks in the 25th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.